(Q44193416)

English

Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT).

scientific article published in November 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT). (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

7

object named as

Robert M Califf

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

A Michael Lincoff

5

object named as

A Michael Lincoff

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

James E. Tcheng

6

object named as

James E Tcheng

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

3

object named as

Craig Balog

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

author name string

M Ashequl Islam

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

James C Blankenship

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Elias A Iliadis

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

EPISTENT Investigators

9

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

language of work or name

0 references

publication date

1 November 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

90

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

916-921

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Prognostic implication of creatine kinase elevation following elective coronary artery interventions.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902653-X

7 January 2021

Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902653-X

7 January 2021

Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902653-X

7 January 2021

Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902653-X

7 January 2021

Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902653-X

7 January 2021

Incidence and mechanism of creatine kinase-MB enzyme elevation after coronary intervention with different devices

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902653-X

7 January 2021

Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions : intravascular ultrasound study of 2256 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902653-X

7 January 2021

Long-term clinical events following creatine kinase--myocardial band isoenzyme elevation after successful coronary stenting

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902653-X

7 January 2021

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902653-X

7 January 2021

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902653-X

7 January 2021

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902653-X

7 January 2021

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902653-X

7 January 2021

Complementary Clinical Benefits of Coronary-Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa Receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902653-X

7 January 2021

Effect of eptifibatide on angiographic complications during percutaneous coronary intervention in the IMPACT--(Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis) II Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902653-X

7 January 2021

Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902653-X

7 January 2021

Recognition of the importance of embolization in atherosclerotic vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902653-X

7 January 2021

ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)—executive summary21When citing this document, the American College of Cardiology and the American Heart Association would appreciate the following cita

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902653-X

7 January 2021

Identifiers

10.1016/S0002-9149(02)02653-X

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44193416&oldid=2108397167"